Name: 4th World Congress on Addiction Medicine and Psychiatry
Start: 2023-10-12
End: 2023-10-14
Location: France

Renowned Speakers

We’ve invited the top most influential speakers from around the world to give inspirational talks and lead practical workshops.

Dr. Y.T. (Ytje) van Pelt

Mental health care specialist, EMDR Europe consultant and trainer Netherlands

Dr. Hamed A. Ranjbar

Professor Koc University Turkey

Joao Paulo Azevedo

Catholic University Portugal

Conference Information

Welcome Message

We are delighted to welcome you all to the 4th World Congress on Addiction Medicine and Psychiatry, which will be held on October 12-14, 2023 in Paris, France.

In order to share their expertise, experiences, and cutting-edge approaches to the problems posed by addiction, Addiction Congress 2023 brings together eminent researchers, scientists, healthcare experts, policymakers, and advocates from around the world.

Addiction Congress 2023 will examine the most recent developments in addiction research and medicine, as well as talk about the most important challenges and cutting-edge strategies for prevention, treatment, and recovery, through keynote addresses, plenary sessions, seminars, and poster presentations.

In addition to the scientific program, Addiction Congress 2023 offers a unique opportunity for networking, collaboration, and mutual learning.

Participants will have the opportunity to meet and interact with colleagues from various backgrounds and disciplines, as well as exchange ideas and insights that will enrich your work and inspire your future endeavours.

We are honored to host this congress in Paris, one of the world's most vibrant and culturally rich cities. We hope you will enjoy Addiction Congress 2023 and make the most of the opportunities it presents.

Let us collaborate to advance addiction medicine and psychiatry while also promoting health, well-being, and social justice for all.

Sincerely
Organizing Committee
Addiction Congress 2023

About Conference

The 4th World Congress on Addiction medicine and psychiatry is a premier event that brings together professionals from various addiction medicine and psychiatry fields.

Addiction Congress 2023 provide a wide range of keynote speeches, plenary sessions, symposia, and workshops on topics like addiction epidemiology, prevention and treatment, drug abuse, behavioral addiction, co-occurring disorders, and more.

Additionally, it gives participants a chance to network with other industry experts, exchange research and clinical insights, and discover cutting-edge technology and solutions for addiction treatment.

Addiction Congress 2023 aims to provide a platform for researchers, clinicians, and other healthcare professionals to discuss and exchange ideas on the latest developments in the field of addiction medicine and psychiatry.

Why should attend?

Addiction Congress 2023 is an excellent way to learn about the latest research, treatments, and best practices in addiction medicine and psychiatry. By attending this conference, you can stay current with the latest developments in the field and gain new insights into how to better treat and manage addiction and mental health disorder.

Attending Addiction Congress 2023 gives you the chance to network with other experts in your area. You can connect with people who share your interests and concerns, such as researchers, clinicians, policymakers, and others.

Who should attend?

Psychiatry specialist
Researchers
Surgeons
Healthcare Administrators
Social workers
Doctors
Scientist
Professors
Therapists
Policy makers
Addiction specialists
Students and Trainee

Benefits of attending the Conference

Opportunities to present your research.
Personal growth and learning about publishing opportunities.
Access to cutting-edge research and new ideas.
Career development opportunities and advancement.
Collaborative opportunities.

Overall, attending a Addiction Congress 2023 can provide numerous benefits related to paper publishing, including networking opportunities, exposure to new perspectives and ideas, and opportunities to present and publish your research.

Abstract Submission

Submitting an abstract for the addiction medicine and psychiatry conference, and presentation will contribute to the session. This presentation will provide valuable insights and recommendations for clinicians, researchers, and policymakers in the field of addiction medicine and psychiatry.

Sessions & Tracks

Addiction Psychiatry

Addiction psychiatry is a medical specialty that focuses on the assessment, diagnosis, and treatment of individuals who are struggling with substance use disorders or other addictive behaviors. In recent years, there has been a significant increase in opioid overdose deaths, leading to a public health crisis. One recent study found that medication-assisted treatment with buprenorphine was associated with a 40% reduction in overdose deaths among people with opioid use disorders. This sessions will cover a variety of addiction psychiatry subtopics, it is not an exhaustive list and there are many other important areas of research and practice within this field.

Substance use disorder
Behavioural addictions
Medication assisted treatment
Dual diagnosis
Public health policy and systems

Addiction and Neuroscience

Addiction and Neuroscience is a field of study that investigates the neural mechanisms that underlie addiction and substance use disorders. It focuses on understanding how the brain is affected by drugs of abuse and how these changes contribute to the development and maintenance of addiction Recent research in Addiction and Neuroscience has made significant contributions to our understanding of the neural mechanisms underlying addiction and substance use disorders. Researchers have identified specific neural circuits involved in addiction, including the mesolimbic dopamine system, which plays a key role in reward processing and addiction.

Drug Reward
Dopamine and Neuroplasticity
Neurocircuitry and Addiction
Interoceptive Awareness
Neuroimaging

Addiction Medicine for health care professionals

Addiction medicine is a rapidly growing field, and it's essential for healthcare professionals to stay up-to-date on the latest research and best practices. Research has shown that integrating addiction treatment into primary care settings can improve access to care and patient outcomes. This includes providing medication-assisted treatment (MAT) for opioid use disorder in primary care settings, as well as screening and brief interventions for other substances. This session will provide an overview of the different types of addiction and their prevalence rates.

Screening and brief interventions
Medication-assisted treatment (MAT)
Co-occurring mental health condition
Motivational interviewing
Addressing health disparities

Addiction drug and Abuse

Addiction to drugs and substance abuse are complex issues that can have significant negative impacts on an individual's physical and mental health, social relationships, and overall well being. A 2021 study published in the Journal of Substance Abuse Treatment found that the COVID-19 pandemic led to increased stress and substance use among individuals with substance use disorders, highlighting the need for continued access to addiction treatment during public health emergencies. This session will examine the different treatment approaches for addiction and explore the challenges of maintaining long-term treatment success.

Neurobiology of addiction
Risk factors for addiction
Diagnosis and assessment of addiction
Treatment approaches for addiction
Prevention of addiction

Addiction and substance use during pregnancy

Addiction and substance use during pregnancy is a significant public health concern as it can have serious consequences for both the mother and the developing fetus. Recent research has shown that opioid use during pregnancy has increased dramatically in recent years, and this increase has been associated with a rise in neonatal abstinence syndrome (NAS). Research has also highlighted the importance of providing comprehensive care for pregnant women with substance use disorders, including access to prenatal care, substance abuse treatment, and social services. session could provide information and resources for healthcare providers, social workers, and other professionals who work with pregnant women who struggle with addiction and substance use. The goal would be to increase understanding of the risks and challenges associated with addiction and substance use during pregnancy.

Neonatal abstinence syndrome (NAS)
Pharmacological treatment
Prevention and intervention
Mental health
Health disparities

Adolescent Addiction and at risk use

Adolescent addiction and at-risk substance use are important public health issues that can have serious short-term and long-term consequences for young people. Here is an overview of some key aspects of adolescent addiction and adolescent addiction refers to the compulsive use of drugs or alcohol despite negative consequences. Recent research highlights the complex nature of adolescent addiction and at-risk use, and emphasizes the importance of addressing multiple factors, such as family dynamics, mental health, and social media use. This sessions will cover related subtopics, healthcare providers, educators, and parents can better identify and address the specific challenges facing adolescents who struggle with addiction and at-risk use.

Opioid epidemic
Vaping and e-cigarettes
Marijuana use
Trauma and adverse childhood experiences
Racial and ethnic disparities

Alcoholism and Drug Addiction

Alcoholism and drug addiction are chronic diseases characterized by compulsive drug-seeking and use despite the harmful consequences. They are considered a major public health concern, affecting individuals and communities worldwide. Researchers have identified several genes that are associated with increased risk of addiction, including those involved in the reward pathway in the brain. This session will provide an overview of several key topics related to alcoholism and drug addiction. The neurobiology and genetics of addiction will be explored, including how changes in brain structure and function can contribute to addictive behaviors.

Neurobiology and genetics of addiction
Co-occurring disorders and dual diagnosis
Pharmacotherapy for addiction
Behavioral therapies for addiction
Prevention of addiction

Pharmacology of Drug Addiction

The pharmacology of drug addiction involves the study of how drugs of abuse interact with the brain and body to produce addictive behaviors. Recent research in the pharmacology of drug addiction, published in the journal Nature Communications found that a specific protein, known as RGS7, may play a key role in regulating opioid receptor signalling in the brain. This sessions will cover a important aspects of the pharmacology of drug addiction. By understanding the neurobiological processes underlying addiction, individual differences in drug responses, and the pharmacokinetics of drugs of abuse, researchers can develop more effective medications for addiction treatment.

Drug tolerance and withdrawal
Medications for addiction treatment
Drug pharmacokinetics
Individual differences in drug responses
Neurotransmitter systems

Alcohol addiction

Alcohol addiction, also known as alcohol use disorder (AUD), is a chronic disease characterized by a compulsive and uncontrollable need to consume alcohol despite the negative consequences it may have on a person's physical health, mental well-being, and social functioning. Research has shown that chronic alcohol use can lead to changes in the brain's reward system and decision-making processes, which can contribute to the development of addiction. This session will cover the potentially dangerous condition of alcohol withdrawal, including symptoms, risk factors, and treatment options. Participants will learn how to recognize alcohol withdrawal and how to provide appropriate medical care for patients experiencing withdrawal.

Alcohol withdrawal
Dual diagnosis
Alcohol-related liver disease
Underage drinking
Harm reduction

Food addiction

Food addiction refers to a behavioral addiction characterized by a compulsion to consume high-calorie, high-fat, and/or high-sugar foods. It is a type of addiction that is similar to drug and alcohol addiction, in that individuals experience a loss of control over their food. Recent research on food addiction has focused on various aspects, including the underlying neural mechanisms, psychological factors, and potential treatments. One recent study published in the journal Obesity Reviews found evidence that sugary and high-fat foods can trigger brain reward pathways and lead to addictive-like eating behaviors in some individuals. This session will focus on the development of effective interventions for food addiction. It may explore the use of pharmacological and non-pharmacological treatments,

Neurobiology of food addiction
Behavioral patterns and food addiction
Diagnosis and measurement of food addiction
Treatment of food addiction
Obesity and food addiction

Social media Addiction

Social media addiction refers to the excessive and compulsive use of social media platforms such as Facebook, Twitter, Instagram, Snapchat, and others. It is a relatively new area of research, but studies have shown that social media addiction can have negative impacts on mental health, including increased anxiety, depression, and loneliness. A 2021 study published in the Journal of Social and Clinical Psychology found that excessive social media use was associated with higher levels of anxiety and depression among young adults. The study also found that reducing social media use led to improvements in mental health. Diagnostic criteria for social media addiction This session will explore the relationship between social media addiction and cognitive function, including attentional control, memory, and decision-making.

The psychology of social media addiction
The impact of social media addiction on mental health
Social media addiction and cognitive function
Social media addiction treatment

Pain and addiction

Pain and addiction are two complex issues that are often interconnected. Pain is a common experience for many people and can be caused by a variety of factors, including injury, illness, or chronic conditions. Recent research has shed light on the complex relationship between pain and addiction, and has highlighted the need for more effective approaches to pain management and addiction treatment can be so severe and chronic that it becomes debilitating and interferes with daily functioning. This session will cover a healthcare providers can gain a better understanding of the complex relationship between pain and addiction, and the range of approaches available for managing pain and preventing addiction.

Medication-assisted treatment for addiction
Prescription drug monitoring program
Alternative pain management approaches
Chronic pain management
Opioid overdose prevention

Child and Adolescent Psychiatry

Child and Adolescent Psychiatry is a specialized field of psychiatry that focuses on the diagnosis, treatment, and prevention of mental health disorders in children and adolescents. With the increasing prevalence of technology in children's and adolescents' lives, research will continue to explore the potential benefits and risks of technology-based interventions for mental health. The Child and Adolescent Psychiatry session would aim to provide an overview of these disorders and their impact on children and adolescents. It may also cover evidence-based treatments and strategies for managing and treating these disorders to improve the mental health and wellbeing of affected children and adolescents.

Developmental disorder
Psychotic disorders
Personality disorders
Neurodevelopmental disorders
Behavioral and conduct disorders

Clinical Psychiatry

Clinical psychiatry is a branch of medicine that specializes in the diagnosis, treatment, and prevention of mental illness. There is ongoing research in clinical psychiatry that aims to improve our understanding of mental illness and develop more effective treatments, Precision psychiatry is an approach that aims to personalize mental health treatment based on an individual's unique genetic, biological, and environmental factors. Researchers are exploring the use of biomarkers and genetic testing to better understand mental illness and develop more targeted treatments. This sessions will covers a wide range of topics related to mental health and illness, and there are many other areas that could be explored as well.

Mood disorders
Anxiety disorders
Psychotic disorders
Personality disorders
Substance abuse disorders

Geriatric psychiatry

Geriatric psychiatry, also known as geropsychiatry, is a branch of psychiatry that focuses on the mental health care of older adults. It addresses the unique mental health needs and challenges that arise in later life, such as cognitive changes, physical health issues, and social isolation. Recent research in geriatric psychiatry has focused on improving the diagnosis and treatment of mental health conditions in older adults, as well as promoting mental wellness and quality of life in later life. This sessions will cover a critical for promoting better mental health outcomes for older adults, improving their quality of life, and providing valuable support for their families and caregivers.

Cognitive disorders
Mood disorders
Psychotic disorders
Sleep disorders
Substance abuse

Forensic psychiatry

Forensic psychiatry is a specialized field of psychiatry that focuses on the intersection between mental health and the law. Recent research study examined the accuracy of risk assessment tools used by forensic psychiatrists to predict future violent behavior in patients. The study found that some commonly used tools were less accurate than others, highlighting the need for ongoing refinement and improvement in this area. In this session, we can discuss how forensic psychiatry relates to the treatment of individuals who have mental health issues and who are involved in legal matters.

Pervasive Developmental Disorder
Child and Adolescent Psychiatry
Intellectual Disability
Learning Disorder
Mental Health

Psychiatric Treatment

Psychiatric treatment involves the diagnosis and management of mental health conditions through a variety of interventions. These interventions can include psychotherapy, medication management, and other forms of supportive care. With the rise of technology, there has been increasing interest in the use of digital interventions, such as mobile apps and online therapy, in the treatment of mental health conditions. Recent research has shown that these interventions can be effective in improving symptoms and increasing access to care. In this session will cover a Investigating the effectiveness of mindfulness-based cognitive therapy in reducing symptoms of anxiety and depression in adults. Analyzing the factors that impact the patient experience of ECT, and exploring ways to optimize the therapeutic benefits while minimizing negative side effects.

Psychotherapy
Electroconvulsive therapy (ECT)
Transcranial magnetic stimulation (TMS)
Dual diagnosis treatment
Psychiatric rehabilitation

Psychiatric Symptoms

Psychiatric symptoms are a wide-ranging set of experiences that can be indicative of a variety of mental health conditions. Research published in the Journal of Clinical Psychiatry in 2020 found that individuals with depression and anxiety had a significantly increased risk of developing Alzheimer's disease later in life, compared to those without these psychiatric symptoms. This sessions will cover a investigating the effectiveness of mindfulness-based interventions in reducing symptoms of depression, anxiety, and sleep disorders in a clinical population.

Depression
Psychosis
Personality disorders
Eating disorders
Sleep disorders

Psychiatry Disorder

Psychiatric disorders refer to a broad range of mental health conditions that affect an individual's thoughts, emotions, and behaviors. These disorders can range from mild to severe and can have a significant impact on an individual's daily functioning and quality of life. This sessions will cover a advances in brain imaging technology have allowed researchers to better understand the neurobiological basis of psychiatric disorders. recent research in psychiatry has led to new treatments and a better understanding of the underlying mechanisms of psychiatric disorders.

Neurocognitive disorders
Treatment adherence
Stigma and discrimination
Comorbidity
Diagnosis and assessment

Psychological Trauma

Psychological trauma refers to the emotional, cognitive, and physical responses that occur after an individual experiences a distressing or life-threatening event. Trauma can have a profound impact on an individual's mental health, leading to symptoms such as anxiety, depression, post-traumatic stress disorder (PTSD), and other mental health condition recent research on psychological trauma has helped to deepen our understanding of the impact of trauma on mental health and has led to the development of more effective interventions and treatments for trauma-related conditions. In this session will cover focus on the impact of trauma on the brain and nervous system. It could explore research on the stress response system, the impact of trauma on brain function and structure, and how these biological changes can contribute to mental health conditions.

Neurobiology of trauma
Adverse childhood experiences (ACEs)
Trauma-informed care
Cultural considerations in trauma
Resilience and post-traumatic growth

Psychological medicine

Psychological medicine practitioners typically include psychiatrists, psychologists, and other mental health professional psychological medicine has seen significant advancements in recent years, particularly in the areas of neuroimaging and molecular genetics. These advances have helped to improve the understanding of the biological and environmental factors that contribute to mental illness and have led to the development of new treatments and therapies for a variety of mental health conditions. In this sessions will cover a treatments have traditionally been considered psychiatric, they are also beneficial in patients without overt psychiatric disorders.

Psychopharmacology
Psychodynamic therapy
Psychotherapy techniques
Psychoanalysis
Psychiatric disorder

Psychotherapy

Psychotherapy, also known as talk therapy, is a form of treatment for mental illnesses that involves talking with a mental health professional. The goal of psychotherapy is to improve a person's mental health and well-being by helping them understand and manage their thoughts, emotions, and behaviors. There is ongoing research in psychotherapy that aims to improve the effectiveness and accessibility of mental health treatment. This sessions will going conduct a exact focus of psychotherapy sessions will vary depending on the individual and their specific mental health needs.

Cognitive-behavioral therapy (CBT)
Psychodynamic therapy
Humanistic therapy
Dialectical behavior therapy (DBT)
Interpersonal therapy

Pharmacology

Pharmacology is the study of how drugs interact with living organisms, including humans. It involves the study of how drugs are absorbed, distributed, metabolized, and eliminated by the body, as well as the effects that drugs have on various physiological processes. Recent research in pharmacology, as the field continues to advance, new discoveries and breakthroughs are likely to emerge, leading to more effective and safer treatments for a range of diseases and conditions. This sessions will cover a these topics are all important areas of study within pharmacology, and are essential for understanding the safety, efficacy, and clinical applications of drugs and we can develop a more comprehensive understanding of how drugs work, how they can be used safely and effectively, and how they can be optimized for individual patients.

Pharmacokinetics
Pharmacodynamics
Pharmacogenomics
Toxicology
Pharmacoeconomics

Market Analysis

Addiction Medicine Market Size and Growth

In 2022, the global Addiction Medicine and Psychiatry market size and growth are difficult to determine separately as they are often combined as a single market segment. However, the global addiction treatment market was valued at USD 4.4 billion in 2022 and was expected to grow at a compound annual growth rate (CAGR) of 6.5% from 2022 to 2027.

The COVID-19 pandemic has also had an impact on the addiction medicine and psychiatry market, as many addiction treatment centers and mental health clinics were forced to temporarily close or reduce their services due to the pandemic. However, the pandemic has also increased the demand for mental health and addiction treatment services, as many people have experienced increased stress, anxiety, and substance use during the pandemic.

It is expected addiction medicine and psychiatry that the market will continue to grow in response to the increasing prevalence of mental health disorder and substance use disorders around the world. The market growth is also attributed to the growing awareness and acceptance of addiction treatment services, as well as advancements in research and development of new treatments and therapies.

Market Segmentation:

The market for addiction treatment can be divided globally based on kind, drug, treatment facilities, distribution method, and geography. The market can be divided into alcohol addiction treatment, nicotine addiction therapy for smokers, opioid addiction treatment, and other categories depending on the type of treatment. The market can be divided into categories for bupropion, varenicline, acamprosate, disulfiram, naltrexone, methadone, buprenorphine, and other drugs depending on the type of substance. Residential treatment centers, outpatient treatment centers, and inpatient treatment centers can be used to divide the market based on the treatment centers. Retail pharmacies, hospital pharmacies, and online pharmacies can all be classified as segments of the market based on the distribution channel. The market addiction therapy can be divided geographically into North America, Europe, Asia, the Pacific, Latin America, the Middle East, and Africa.

Addiction Medicine Global Level Market:

The global market analysis for addiction medicine and psychiatry indicates a steady growth rate due to increasing demand for addiction treatment and mental health service. The market is expected to continue growing in the future due to rising awareness and acceptance of addiction treatment, increased funding for research and development of new treatments, and the growing prevalence of mental health disorder and substance use disorders worldwide.

According to a report by Grand View Research, the global addiction treatment market was valued at USD 4.4 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 6.5% from 2020 to 2027. The report credits increased government initiatives, growing public awareness of substance use problems, and the availability of cutting-edge treatments for the expansion of the market for addiction therapy.

Overall, the market analysis for addiction medicine and psychiatry indicates a positive growth trend at the global level, with increasing demand for addiction treatment and mental health service driving the growth of the market.

Addiction Treatment Market Outlook

The market for addiction treatment was anticipated to grow at a CAGR of 6.7% throughout the anticipated time frame. The rate of adoption in business settings is anticipated to increase significantly, creating a potential opportunity worth US$ 50 Mn over the next ten years.

Sharing mouthpieces and hoses is common while using smoking products like water pipes, which makes it easier for the new coronavirus to spread in public and social settings. Patients are put in danger when they have conditions that make them more dependent on oxygen or that impair their bodies' capacity to utilize it effectively by increasing their susceptibility to life-threatening lung infections like pneumonia.

Addiction Medicine and Psychiatry Market in different Countries:

The addiction medicine and psychiatry market vary across different countries depending on factors such as healthcare systems, cultural attitudes towards addiction and mental health, availability of resources, and government policies.

United States:

The addiction medicine and psychiatry market in the US is quite large and well-developed, with a significant focus on both medication-assisted treatment (MAT) and behavioral therapy. In recent years, there has been a particular emphasis on addressing the opioid epidemic through expanded access to MAT and increased funding for addiction treatment. The US also has a large market for psychiatric medications, with a significant portion of the population taking antidepressants, antipsychotics, and other drugs to manage mental health conditions.

Canada:

Canada's addiction medicine and psychiatry market is somewhat similar to that of the US, with a focus on both MAT and behavioral therapy. However, the availability of resources can vary widely depending on the province or territory. Some areas have robust addiction and mental health services, while others have long wait times or limited resources. Canada also has a significant market for psychiatric medications, with antidepressants and antipsychotics being among the most commonly prescribed drugs.

United Kingdom:

The addiction medicine and psychiatry market in the UK is primarily focused on the National Health Service (NHS), which provides free healthcare to all citizens. The NHS offers a range of addiction and mental health services, including both pharmacological and psychosocial treatments. However, there are concerns about long wait times and limited access to certain treatments in some areas. The UK also has a significant market for psychiatric medications, although the government has recently implemented guidelines to reduce overprescribe

Australia:

Australia's addiction medicine and psychiatry market is similar to that of Canada, with a focus on both MAT and behavioral therapy. However, there are concerns about the accessibility of services in rural and remote areas. Australia also has a significant market for psychiatric medications, with antidepressants being among the most commonly prescribed drugs.

Why France?

France has a long history of addiction treatment, with some of the earliest addiction treatment facilities in the world. It has been at the forefront of developing evidence-based approaches to addiction treatment.

France is home to some of the leading addiction research institutions in the world, including the French National Institute for Health and Medical Research (INSERM), which is known for its ground breaking research on addiction.

France has a well-developed healthcare system, with high-quality medical facilities and well-trained healthcare professionals. This makes it an ideal location for hosting a medical conference of this scale.

France is centrally located in Europe, with excellent transport links to other parts of the world. This makes it easy for delegates from all over the world to attend the conference.

4th World Congress on
Addiction Medicine and Psychiatry

Quick Links

Theme: Addiction and Psychiatry: The Recent Advances in Medication & Treatment Strategies